EUVIMEDEUVIMED entdecken
Fallbericht

JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome

Nathan M Krah, Laura Miotke, Peng Li, Jay L Patel, Anneli R Bowen, Anthony D Pomicter, Ami B Patel

Journal of the National Comprehensive Cancer Network · 2023

DOI: 10.6004/jnccn.2023.7068 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023. Verfasst von Nathan M Krah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Utah, Salt Lake City, Utah. Hauptthemen laut MEDLINE: Thrombocytosis, Myeloproliferative Disorders, Leukemia, Eosinophilia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 66-year-old male presented with hypereosinophilia, thrombocytosis, extensive thrombosis refractory to direct oral anticoagulant therapy, and evidence of end-organ damage, including rash, splenic infarcts, and pulmonary infiltrates. Bone marrow biopsy revealed myeloid malignancy consistent with both chronic eosinophilic leukemia and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) with SF3B1 mutation and thrombocytosis. Next-generation sequencing of the patient’s eosinophils and neutrophil compartments revealed pathologic variants in EZH2 and SF3B1 in addition to a noncanonical JAK2 R683S mutation that has not been previously described in myeloproliferative disorders or other chronic myeloid neoplasms. These mutations were not present in the patient’s lymphoid cell fraction, suggesting that the hematopoietic malignancy arose in a myeloid-committed progenitor cell. Based on this case and previous work from our group, we propose that noncanonical JAK2 mutations may permit signal transduction that biases toward eosinophilic differentiation in chronic myeloid neoplasms. Although the patient’s blood counts initially responded to ruxolitinib and hydroxyurea, the response was not durable. Early referral for allogenic bone marrow transplant appears necessary to prevent long-term complications and disease progression in myeloid neoplasms with clonal hypereosinophilia driven by noncanonical JAK2 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytosisMyeloproliferative DisordersLeukemiaEosinophiliaMyelodysplastic SyndromesMaleDiagnosis, Dual (Psychiatry)Hypereosinophilic SyndromeMutationHumansAgedJanus Kinase 2

Stichwörter der Autor:innen

JAK2eosinophilialeukemiamyelodysplastic syndromemyeloproliferative syndrome

Substanzen

JAK2 protein, humanJanus Kinase 2

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
  • Division of Hematopathology, Department of Pathology, University of Utah, Salt Lake City, Utah.
  • Genomics Laboratory, ARUP Laboratories, Salt Lake City, Utah.
  • Department of Dermatology, University of Utah, Salt Lake City, Utah.
  • Division of Hematology Biorepository, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, Utah.

Förderung

  • NCI NIH HHS

Zitieren

APA

Krah, N. M., Miotke, L., Li, P., Patel, J. L., Bowen, A. R., Pomicter, A. D., & Patel, A. B. (2023). JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2023.7068

Vancouver

Krah NM, Miotke L, Li P, Patel JL, Bowen AR, Pomicter AD, et al. JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome. Journal of the National Comprehensive Cancer Network. 2023. doi:10.6004/jnccn.2023.7068

BibTeX
@article{Krah2023,
  author = {Krah, Nathan M and Miotke, Laura and Li, Peng and Patel, Jay L and Bowen, Anneli R and Pomicter, Anthony D and Patel, Ami B},
  title = {JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2023},
  doi = {10.6004/jnccn.2023.7068}
}
Kostenlos starten →